Jessica Hagen

Industry voices discuss where AI will make the biggest impact in the healthcare workforce and which positions may be affected by automation.

The extension allows providers to continue remotely prescribing Schedule II–V controlled substances under specific conditions to prevent a disruptive "telemedicine cliff."

The Health Benefits Alliance will integrate Healthee's AI-enabled benefits navigation platform, including its virtual assistant Zoe, into HBA’s programs.

Alongside warnings around AI, healthcare executives say the technology has long-term potential to improve clinical workflows and patient outcomes, making 2025 a year of both excitement and cautious scrutiny.

Applied Tissue Technologies’ NPWT device and micrografting kit will be added to New Horizon Medical Solutions' portfolio, expanding the company's wound care offerings.

Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will sell medicines at a discounted price on TrumpRx.

The proposed class action lawsuit against the San Diego-based health system alleges that a patient's medical visit was recorded using Abridge without his consent, violating California privacy laws.

Executives weigh in on current valuations and hype around AI in the healthcare sector and what it could mean for the future.

Virtual pediatric care company Clarity Pediatrics garners $14.5 million to expand into obesity care.

The company will use the funds to accelerate commercialization of its brain-signal AI technology and expand its cognitive health applications.